Carregant...
Non-inferiority Trials Using a Surrogate Marker as a Primary Endpoint: An Increasing Phenotype in Cardiovascular Trials
BACKGROUND/AIMS: Non-inferiority trials are increasing in cardiovascular medicine, with approval of many drugs and devices on the basis of such studies. Surrogate markers as primary endpoints have been also more frequently used for efficient assessment of cardiovascular interventions. However, there...
Guardat en:
| Publicat a: | Clin Trials |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8088773/ https://ncbi.nlm.nih.gov/pubmed/32838556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774520949157 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|